No black box warning on record for Symbravo
As of the latest FDA labeling reviewed, Symbravo (MELOXICAM, RIZATRIPTAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Symbravo medicine page for the complete safety profile.